Lupin launches generic Onfi

BY Sandra Levy

Lupin is introducing its generic Onfi (clobazam tablets). The product, which was previously approved by the Food and Drug Administration, will be available in 10-mg and 20-mg dosage strengths.

Lupin’s generic of Lundbeck’s branded drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years of age or older.

Clobazam tablets in 10- and 20-mg strength have a market value of roughly $479 million, according to March 2019 IQVIA data.


Leave a Reply

No comments found



What area is your company focused most on in 2019?
  • Add your answer